BioElectronics (BIEL) Stock Statistics & Valuation Metrics
Total Valuation
BioElectronics has a market cap or net worth of $7.41M. The enterprise value is $22.76T.
- Market Cap
- $7.41M
- Enterprise Value
- $22.76T
Share Statistics
BioElectronics has 24,705,066,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 24,705,066,000
- Owned by Insiders
- ―
- Owned by Institutions
- <0.01%
Financial Efficiency
BioElectronics’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is -4.92%.
- Return on Equity (ROE)
- 0.03
- Return on Assets (ROA)
- -3.74
- Return on Invested Capital (ROIC)
- -4.92%
- Return on Capital Employed (ROCE)
- -0.02
- Revenue Per Employee
- 56.74K
- Profits Per Employee
- -59.17K
- Employee Count
- 9
- Asset Turnover
- 3.59
- Inventory Turnover
- 2.51
Valuation Ratios
The current PE Ratio of BioElectronics is -13.92. BioElectronics’s PEG ratio is -0.14.
- PE Ratio
- -13.92
- PS Ratio
- 14.51
- PB Ratio
- -0.41
- Price to FCF
- -48.95
- Price to Operating Cash Flow
- -48.95
- PEG Ratio
- -0.14
Income Statement
In the last 12 months, BioElectronics had revenue of 510.62K and earned -532.49K in profits. Earnings per share was 0.00.
- Revenue
- 510.62K
- Gross Profit
- 433.35K
- Operating Income
- 81.27K
- Pretax Income
- -532.49K
- Net Income
- -532.49K
- EBITDA
- 81.27K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -472.15K and capital expenditures 0, giving a free cash flow of -472.15K billion.
- Operating Cash Flow
- -472.15K
- Free Cash Flow
- -472.15K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
BioElectronics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.04%
- Earnings Yield
- -7.18%
Stock Price Statistics
- Beta
- 1.60
- 52-Week Price Change
- ―
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
BioElectronics as a current ratio of 0.04, with Debt / Equity ratio of -90.79%
- Current Ratio
- 0.04
- Quick Ratio
- 0.03
- Debt to Market Cap
- 1.65
- Net Debt to EBITDA
- 200.40
- Interest Coverage Ratio
- 0.13
Taxes
In the past 12 months, BioElectronics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
BioElectronics EV to EBITDA ratio is 291.61, with an EV/FCF ratio of -156.51.
- EV to Sales
- 46.41
- EV to EBITDA
- 291.61
- EV to Free Cash Flow
- -156.51
- EV to Operating Cash Flow
- -156.51
Balance Sheet
BioElectronics has $6,871.00 in cash and marketable securities with $14.23M in debt, giving a net cash position of -$14.22M billion.
- Cash & Marketable Securities
- $6,871.00
- Total Debt
- $14.23M
- Net Cash
- -$14.22M
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 84.87%, with operating margin of 15.91%, and net profit margin of -104.28%.
- Gross Margin
- 84.87%
- Operating Margin
- 15.91%
- Pretax Margin
- -104.28%
- Net Profit Margin
- -104.28%
- EBITDA Margin
- 15.91%
- EBIT Margin
- 15.91%
